Endocrinology
Stellate ganglion block as a treatment for vasomotor symptoms: Clinical applicationHormone therapy is the mainstay of treatment, but there is a clear need for safe and effective nonhormonal options. The authors review data on the use of stellate ganglion block in perimenopausal and postmenopausal patients.
- Vitamin D supplementation: Pearls for practicing clinicians
A review of how to assess and counsel patients on the use of vitamin D, with patient scenarios clinicians are likely to encounter, and an overview of current recommendations for vitamin D supplementation.
- Hypercalcemia and vitamin A: A vitamin to keep in mind
Vitamin A toxicity can affect bone resorption and hypercalcemia and should be explored in unexplained cases of parathyroid hormone-independent hypercalcemia.
- A large, painless bulla on the right foot
A patient with a history of type 2 diabetes and diabetic neuropathy had a hemoglobin A1c of 10.3% at presentation.
- DXA and fracture risk assessment
The following article contained an error: Williams S, Khan L, Licata AA. DXA and clinical challenges of fracture risk assessment in primary care. Cleve Clin J Med 2021; 88(11):615–622. doi:10.3949/ccjm.88a.20199
- SGLT-2 inhibitors are potential game-changers (for more than diabetes)
Data from large clinical trials and improved understanding of the biologic effects of these drugs are changing expectations for the clinical course in patients with diabetes, as well as chronic kidney disease and heart failure.